Forum: her2group
12-07-2019, 12:54 PM
|
Replies: 0
Views: 1,571
NSABP FB-7 paclitaxel + herceptin +/_neratinib
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 + breast cancer | Breast Cancer...
|